XML 82 R71.htm IDEA: XBRL DOCUMENT v3.26.1
EQUITY-BASED INCENTIVE PLANS - Nonvested Restricted Stock Activity (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2026
USD ($)
$ / shares
shares
RSAs  
Shares  
Number of nonvested shares outstanding, beginning 0
Nonvested shares granted 10,395
Nonvested shares vested (10,395)
Nonvested shares forfeited 0
Number of nonvested shares outstanding, ending 0
Weighted Average Grant Date Fair Value  
Weighted average exercise price outstanding, beginning (in usd per share) | $ / shares $ 0
Weighted average exercise price outstanding, nonvested options granted (in usd per share) | $ / shares 4.81
Weighted average exercise price outstanding, options vested (in usd per share) | $ / shares 4.81
Weighted average exercise price outstanding, options forfeited (in usd per share) | $ / shares 0
Weighted average exercise price outstanding, ending (in usd per share) | $ / shares $ 0
RSUs  
Shares  
Nonvested shares vested (181,691)
Number of nonvested shares outstanding, ending 68,028
Unrecognized stock-based compensation expense | $ $ 233
Restricted Shares  
Nonvested restricted stock outstanding, beginning balance (in shares) 502,019
Nonvested restricted stock granted (in shares) 0
Nonvested restricted stock vested (in shares) (171,296)
Nonvested restricted stock forfeited (in shares) 0
Nonvested restricted stock outstanding, ending balance (in shares) 330,723
Weighted Average Grant Date Fair Value  
Weighted average exercise price outstanding, beginning (in usd per share) | $ / shares $ 4.11
Weighted average exercise price outstanding, nonvested options granted (in usd per share) | $ / shares 0
Weighted average exercise price outstanding, options vested (in usd per share) | $ / shares 4.14
Weighted average exercise price outstanding, options forfeited (in usd per share) | $ / shares 0
Weighted average exercise price outstanding, ending (in usd per share) | $ / shares $ 4.10
Weighted average remaining vesting period 2 months 12 days
Performance Shares  
Shares  
Unrecognized stock-based compensation expense | $ $ 322
Restricted Shares  
Nonvested restricted stock outstanding, beginning balance (in shares) 1,981,464
Nonvested restricted stock granted (in shares) 0
Nonvested restricted stock vested (in shares) 0
Nonvested restricted stock forfeited (in shares) 0
Nonvested restricted stock outstanding, ending balance (in shares) 1,981,464
Weighted Average Grant Date Fair Value  
Weighted average exercise price outstanding, beginning (in usd per share) | $ / shares $ 4.61
Weighted average exercise price outstanding, nonvested options granted (in usd per share) | $ / shares 0
Weighted average exercise price outstanding, options vested (in usd per share) | $ / shares 0
Weighted average exercise price outstanding, options forfeited (in usd per share) | $ / shares 0
Weighted average exercise price outstanding, ending (in usd per share) | $ / shares $ 4.61
Weighted average remaining vesting period 2 months 12 days